PTC-2107
Asset
Targets declining mitochondrial membrane potential to restore mitochondrial efficiency and induce senescent-cell apoptosis.
- Stage
- Preclinical
- Modality
- Peptide
- Target
- Not known
- 0
- Indications
- 0
- Trials
- 1
- Developer
Indications
1No named disease
Preclinical, eossenolytix.com, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.